Approval · Notice of Compliance 5686 · 1994
INTRON A: Notice of Compliance 5686
Issued June 9, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5686
- Date
- June 9, 1994
- Company
- Schering Canada Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New indication
- Therapeutic class
- Biological response modifier
Products in this notice
Medicinal ingredients
- INTERFERON ALFA 2B 5,000,000 UNIT per VIAL
- INTERFERON ALFA 2B 3,000,000 UNIT per VIAL
- INTERFERON ALFA 2B 10,000,000 UNIT per VIAL